Northern Trust’s Bright Minds Biosciences DRUG Stock Holding History

Northern Trust’s Portfolio DRUG Stock Details DRUG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98M	Buy	42,466 +5,088	+14%	+$400K	﹤0.01%	2910
2026 Q1	$2.73M	Buy	37,378 +11,808	+46%	+$950K	﹤0.01%	2807
2025 Q4	$2M	Sell	25,570 -1,643	-6%	-$110K	﹤0.01%	3002
2025 Q3	$1.65M	Buy	27,213 +1,587	+6%	+$61.6K	﹤0.01%	3138
2025 Q2	$669K	Buy	+25,626	New	+$768K	﹤0.01%	3555

Other funds holding DRUG

Jupiter Topco New York $245B AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Northern Trust's DRUG Position: Q2 2026 in Review

Northern Trust increased its Bright Minds Biosciences (DRUG) stake by 14% in Q2 2026, buying an estimated $400K and bringing the position to 42,466 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

Northern Trust first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

Northern Trust held 42,466 shares of Bright Minds Biosciences worth $2.98M as of Q2 2026.
Northern Trust bought 5,088 Bright Minds Biosciences shares in Q2 2026, an estimated $400K.
Bright Minds Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2910 holding.
Northern Trust first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.